心外膜脂肪组织与心血管疾病和代谢性疾病

摘要/Abstract

中图分类号:

吴昊, 白英, 邓可武. 心外膜脂肪组织与心血管疾病和代谢性疾病[J]. 内科理论与实践, 2021, 16(03): 208-211.

参考文献31

[1]	Salazar J, Luzardo E, Mejías JC, et al. Epicardial fat: physiological, pathological, and therapeutic implications[J]. Cardiol Res Pract, 2016, 2016: 1291537.
[2]	Neeland IJ, Ross R, Després JP, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement[J]. Lancet Diabetes Endocrinol, 2019, 7(9): 715-725. doi:10.1016/S2213-8587(19)30084-1 URL
[3]	Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk[J]. Int J Mol Sci, 2019, 20(23): 5989. doi:10.3390/ijms20235989 URL
[4]	Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction[J]. Obes Res, 2003, 11(2): 304-310. pmid:12582228
[5]	Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis[J]. Metab Syndr Relat Disord, 2014, 12(1): 31-42. doi:10.1089/met.2013.0107 URL
[6]	Ansari MA, Mohebati M, Poursadegh F, et al. Is echocardiographic epicardial fat thickness increased in patients with coronary artery disease? A systematic review and meta-analysis[J]. Electron Physician, 2018, 10(9): 7249-7258. doi:10.19082/7249 URL
[7]	Bachar GN, Dicker D, Kornowski R, et al. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects[J]. Am J Cardiol, 2012, 110(4): 534-538. doi:10.1016/j.amjcard.2012.04.024pmid:22579086
[8]	Toya T, Corban MT, Imamura K, et al. Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction[J]. Atherosclerosis, 2020, 302: 27-35. doi:10.1016/j.atherosclerosis.2020.04.012 URL
[9]	Al Chekakie MO, Welles CC, Metoyer R, et al. Pericardial fat is independently associated with human atrial fibrillation[J]. J Am Coll Cardiol, 2010, 56(10): 784-788. doi:10.1016/j.jacc.2010.03.071pmid:20797492
[10]	Gaeta M, Bandera F, Tassinari F, et al. Is epicardial fat depot associated with atrial fibrillation[J]?. Europace, 2017, 19(5): 747-752. doi:10.1093/europace/euw398 URL
[11]	Sepehri Shamloo A, Dagres N, Dinov B, et al. Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation[J]?. Int J Cardiol Heart Vasc, 2019, 22: 132-138.
[12]	Erdogan G, Belen E, Sungur MA, et al. Assessment of epicardial adipose tissue thickness in patients with resistant hypertension[J]. Blood Press Monit, 2016, 21(1): 16-20. doi:10.1097/MBP.0000000000000149pmid:26317386
[13]	Song Y, Song F, Wu C, et al. The roles of epicardial adipose tissue in heart failure[J]. Heart Fail Rev, 2020. [Epub ahead of print].
[14]	Koepp KE, Obokata M, Reddy YNV, et al. Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction[J]. JACC Heart Fail, 2020, 8(8): 657-666. doi:10.1016/j.jchf.2020.04.016 URL
[15]	van Woerden G, Gorter TM, Westenbrink BD, et al. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction[J]. Eur J Heart Fail, 2018, 20(11): 1559-1566. doi:10.1002/ejhf.1283pmid:30070041
[16]	Li Y, Liu B, Li Y, et al. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis[J]. Cardiovasc Diabetol, 2019, 18(1): 3. doi:10.1186/s12933-019-0807-3 URL
[17]	Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features[J]. Trends Endocrinol Metab, 2011, 22(11): 450-457. doi:10.1016/j.tem.2011.07.003 URL
[18]	Sayin I, Erkan AF, Ekici B, et al. Thickening of the epicardial adipose tissue can be alleviated by thyroid hormone replacement therapy in patients with subclinical hypothyroidism[J]. Kardiol Pol, 2016, 74(12): 1492-1498. doi:10.5603/KP.a2016.0053 URL
[19]	王怡文, 王侃侃, 宋玉玲, 等. 亚临床甲状腺功能减退症与心外膜脂肪组织厚度相关性的Meta分析[J]. 滨州医学院学报, 2019, 42(3): 188-212.
[20]	Altunbaş R, Eren MA, Altıparmak IH, et al. The relation between epicardial fat tissue thickness and TSH receptor antibody in hyperthyroidism[J]. Exp Clin Endocrinol Diabetes, 2019, 127(1): 37-40.
[21]	Liu B, Li Y, Li Y, et al. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis[J]. Hepatol Int, 2019, 13(6): 757-765. doi:10.1007/s12072-019-09972-1 URL
[22]	Meng X, Wang W, Zhang K, et al. Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population[J]. Ther Clin Risk Manag, 2018, 14: 1499-1506. doi:10.2147/TCRM.S168345 URL
[23]	Lin A, Wong ND, Razipour A, et al. Metabolic syndrome, fatty liver, and artificial intelligence-based epicardial adipose tissue measures predict long-term risk of cardiac events: a prospective study[J]. Cardiovasc Diabetol, 2021, 20(1): 27. doi:10.1186/s12933-021-01220-x URL
[24]	Chacińska M, Zabielski P, Ksiazek M, et al. The impact of OMEGA-3 fatty acids supplementation on insulin resistance and content of adipocytokines and biologically active lipids in adipose tissue of high-fat diet fed rats[J]. Nutrients, 2019, 11(4): 835. doi:10.3390/nu11040835 URL
[25]	Ziyrek M, Kahraman S, Ozdemir E, et al. Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients[J]. Rev Port Cardiol, 2019, 38(6): 419-423. doi:10.1016/j.repc.2018.08.010 URL
[26]	Grosso AF, de Oliveira SF, Higuchi Mde L, et al. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome[J]. Diabetol Metab Syndr, 2014, 6(1): 47. doi:10.1186/1758-5996-6-47 URL
[27]	Iacobellis G, Mohseni M, Bianco SD, et al. Liraglutide causes large and rapid epicardial fat reduction[J]. Obesity (Silver Spring), 2017, 25(2): 311-316. doi:10.1002/oby.21718 URL
[28]	Bizino MB, Jazet IM, de Heer P, et al. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation[J]. Diabetologia, 2020, 63(1): 65-74. doi:10.1007/s00125-019-05021-6 URL
[29]	Braha A, Timar B, Diaconu L, et al. Dynamics of epicardiac fat and heart function in type 2 diabetic patients initiated with SGLT-2 inhibitors[J]. Diabetes Metab Syndr Obes, 2019, 12: 2559-2566. doi:10.2147/DMSO.S223629 URL
[30]	Parisi V, Petraglia L, D'Esposito V, et al. Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue[J]. Int J Cardiol, 2019, 274: 326-330. doi:10.1016/j.ijcard.2018.06.106 URL
[31]	Launbo N, Zobel EH, von Scholten BJ, et al. Targeting epicardial adipose tissue with exercise, diet, bariatric surgery or pharmaceutical interventions[J]. Obes Rev, 2021, 22(1): e13136.

心外膜脂肪组织与心血管疾病和代谢性疾病

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献31

相关文章15

编辑推荐

Metrics

本文评价

[1]	陆林, 代杨, 王晓群, 吴立群, 张瑞岩, 沈卫峰.心血管转化研究的若干进展[J]. 内科理论与实践, 2022, 17(05): 369-372.
[2]	施仲伟.回眸过去30年全球和中国的心血管疾病负担及其危险因素——1990年至2019年全球心血管疾病负担及其危险因素报告解读[J]. 诊断学理论与实践, 2021, 20(04): 349-355.
[3]	晏焕青, 谢琼虹, 尚达, 戴淑琪, 朱彤莹.胎球蛋白A对腹膜透析患者冠状动脉钙化发生起始的影响因素分析[J]. 内科理论与实践, 2021, 16(01): 49-52.
[4]	吴歆, 耿旭强, 徐沪济.多基因风险评分在复杂性状疾病中的应用进展[J]. 诊断学理论与实践, 2020, 19(05): 540-543.
[5]	缪培智,.达格列净在心血管疾病中的作用研究进展[J]. 内科理论与实践, 2020, 15(02): 77-81.
[6]	倪瀚文, 吴立群.外泌体在心肌缺血及房颤诊治中的应用前景研究进展[J]. 诊断学理论与实践, 2020, 19(02): 199-202.
[7]	陈瑶瑶, 顾爱华.氧化三甲胺与心血管疾病关系的研究进展[J]. 诊断学理论与实践, 2019, 18(2): 237-240.
[8]	张翼飞, 洪洁, 石娟, 顾彬, 王姝洁, 顾卫琼.多学科诊疗模式在代谢性疾病教学中的应用[J]. 诊断学理论与实践, 2017, 16(04): 449-451.
[9]	李俊伟, 夏寒冰, 赵红丽, 刘淑霞.基于超声测量的心外膜脂肪组织厚度预测冠心病的价值[J]. 诊断学理论与实践, 2017, 16(03): 324-327.
[10]	何立芸,.冠状动脉微血管功能与心血管疾病预后[J]. 内科理论与实践, 2017, 12(01): 37-41.
[11]	戴秋艳,.女性冠心病与微循环障碍[J]. 内科理论与实践, 2017, 12(01): 9-14.
[12]	袁伟, 卢洪洲,.人类免疫缺陷病毒感染与心血管疾病的研究进展[J]. 内科理论与实践, 2016, 11(05): 316-318.
[13]	陈国芳, 刘超,.限食对代谢性疾病的影响及其相关机制[J]. 诊断学理论与实践, 2016, 15(04): 346-349.
[14]	桂燕萍, 施仲伟,.超声测量心外膜脂肪组织厚度在慢性心力衰竭患者中的临床价值[J]. 诊断学理论与实践, 2016, 15(03): 248-252.
[15]	沈思钰, 朱培元, 傅晓东,.系统性红斑狼疮与他汀类药物治疗的关系[J]. 内科理论与实践, 2016, 11(01): 60-62.